William Blair & Company
FLGT icon

William Blair & Company’s Fulgent Genetics FLGT Stock Holding History

William Blair & Company’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,605
Closed -$252K – 1904
2021
Q1 		$252K Buy
+2,605
New +$269K ﹤0.01% 1397
2017
Q4 		– Sell
-25,328
Closed -$121K – 1392
2017
Q3 		$121K Sell
25,328
-992
-4% -$5.7K ﹤0.01% 1298
2017
Q2 		$168K Hold
26,320
– – ﹤0.01% 1375
2017
Q1 		$287K Buy
+26,320
New +$311K ﹤0.01% 1090

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair & Company's FLGT Position: Q2 2021 in Review

William Blair & Company sold out of Fulgent Genetics (FLGT) in Q2 2021, closing a stake of 2,605 shares — an estimated $252K sold.

William Blair & Company first reported a position in FLGT in Q1 2017 and held it in 4 quarters. The position peaked at $287K in Q1 2017. 254 funds tracked by Wall St. Rank hold FLGT as of Q2 2021.

  • William Blair & Company reported no remaining Fulgent Genetics position as of Q2 2021 after selling out during the quarter.
  • William Blair & Company sold 2,605 Fulgent Genetics shares in Q2 2021, an estimated $252K.
  • William Blair & Company first reported a position in Fulgent Genetics in Q1 2017 and held it in 4 quarters.
  • William Blair & Company's Fulgent Genetics position peaked at $287K in Q1 2017.
  • 254 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2021.

Based on William Blair & Company's 13F filing for Q2 2021, filed 12 Aug 2021.